CD101 topical regulatory update

FDA granted Fast Track and Qualified Infectious Disease Product (QIDP) designations to CD101 topical to treat vulvovaginal candidiasis (VVC) and prevent recurrent VVC. In mid-2016, Cidara plans to sta...